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Abstract
 
Inactivation of the autoimmune regulator (Aire) gene causes a rare recessive disorder, autoimmune
polyendocrine syndrome 1 (APS1), but it is not known if Aire-dependent tolerance mechanisms
are susceptible to the quantitative genetic changes thought to underlie more common autoimmune
diseases. In mice with a targeted mutation, complete loss of Aire abolished expression of an insulin
promoter transgene in thymic epithelium, but had no effect in pancreatic islets or the testes. Loss
of one copy of Aire diminished thymic expression of the endogenous insulin gene and the trans-
gene, resulting in a 300% increase in islet-reactive CD4 T cells escaping thymic deletion in T cell
receptor transgenic mice, and dramatically increased progression to diabetes. Thymic deletion
induced by antigen under control of the thyroglobulin promoter was abolished in Aire homozy-
gotes and less efficient in heterozygotes, providing an explanation for thyroid autoimmunity in
APS1. In contrast, Aire deficiency had no effect on thymic deletion to antigen controlled by a
systemic H-2K promoter. The sensitivity of Aire-dependent thymic deletion to small reductions
in function makes this pathway a prime candidate for more subtle autoimmune quantitative trait
loci, and suggests that methods to increase Aire activity would be a potent strategy to lower the in-
cidence of organ-specific autoimmunity.
Key words: diabetes mellitus type I • autoimmune diseases • clonal deletion • 
immune tolerance • thymus
 
Introduction
 
Organ-specific tolerance was originally thought to depend
primarily on a passive process of immunological “igno-
rance” due to sequestration of the antigen from naive T
cells (1), or upon peripheral tolerance mechanisms such as
peripheral deletion (2–4), anergy (4), or suppression by reg-
ulatory T cells (5, 6). However, a growing body of evi-
dence indicates that the thymus establishes organ-specific
tolerance via promiscuous expression of organ-specific anti-
gens  and deletion of forbidden clones with high avidity
TCRs against these antigens (7–15). There is also increas-
ing evidence that a failure in promiscuous thymic expres-
sion may result in autoimmunity. Thymic expression of
myelin proteolipid protein induces clonal deletion of proteo-
lipid protein–reactive T cells (16), but the thymus of SJL
mice (like the DBA/2 and B6 strains) expresses a splice
variant from this gene lacking a dominant epitope that coin-
cides with a high frequency of encephalitogenic T cells in
the periphery (17). In human type 1 diabetes, a frequent
susceptibility allele of 
 
IDDM2
 
 corresponds to a polymor-
phism in the insulin gene promoter that lowers thymic ex-
pression of pro-insulin mRNA only approximately two- to
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threefold (18, 19), raising the question of whether or not
thymic deletion is sensitive to such subtle changes in thy-
mic antigen levels.
A major advance establishing the significance of thy-
mic tolerance to organ-specific gene products has come
through the study of autoimmune polyendocrine syndrome
1 (APS1), a rare monogenic human disorder caused by ho-
mozygous mutations in autoimmune regulator (
 
AIRE
 
; ref-
erences 20 and 21). Clinical manifestations of APS1 include
a constellation of organ-specific autoimmune diseases (22).
Autoimmune thyroid disease occurs as part of the spectrum
in 
 
 
 
13% of APS1 patients, and type 1 diabetes is present at
a similar rate, potentially dependent on the MHC. The
Aire protein localizes in nuclear speckles (23, 24), interacts
with CBP (transcriptional coactivator CREB-binding pro-
tein; reference 25), and is able to activate transcription in
luciferase assays (25, 26). Aire is expressed most highly in
scattered thymic medullary epithelial cells (23, 27, 28). 
 
Aire
 
knockout mice develop a range of organ-specific autoim-
mune manifestations comparable to human APS1 (27, 29).
Anderson et al. (29) showed that autoimmunity is con-
ferred by transplantation of an 
 
Aire
 
-deficient thymus, and
thymic medullary epithelial cells isolated from 
 
Aire
 
 knock-
out mice had lost promiscuous expression of a large num-
ber of organ-specific mRNAs including proinsulin mRNA.
Liston et al. (30) showed that the thymus in 
 
Aire
 
 knockout
mice had lost the ability to delete high avidity CD4
 
  
 
T cells
recognizing a transgenic antigen controlled by the insulin
promoter.
So far, no information exists regarding 
 
Aire
 
’s role in thy-
mic expression of thyroid-specific antigens, despite the fact
that autoimmune thyroid disease is the most common au-
toimmune disease and subclinical thyroiditis occurs in up to
10% of women. Moreover, it is unknown if 
 
Aire
 
-depen-
dent thymic deletion is a well-buffered process that is only
disrupted in this rare monogenic autoimmune disease, or
alternatively, if it is a process prone to failure through the
actions of more subtle, quantitative reductions in the path-
way as are more likely to occur in common polygenic au-
toimmune diseases. Here, we show that 
 
Aire
 
 is essential for
thymic expression and thymic deletion to antigen under is-
let- and thyroid-specific promoters, but not under a sys-
temic promoter, and that 
 
Aire
 
-induced elimination of for-
bidden clones of organ-specific cells is exquisitely sensitive
to small functional reductions.
 
Materials and Methods
 
Mice.
 
3A9 TCR transgenic (31), ILK-3 Ins–hen egg lysozyme
(HEL) transgenic (32), TLK3 Tg:mHEL transgenic (32, 33), and
KLK4 H-2k:mHEL transgenic mice (34) produced in C57BL/6J
mice were backcrossed more than seven generations to B10.Br/
SgSnJ (JAX). (B6 
 
  
 
129/Sv)F2 
 
Aire
 
 
 
/0 
 
mice (27) were back-
crossed to the three strains of HEL:3A9 B10.Br mice for two
generations. Backcross offspring were typed for TCR, HEL, H-2
(32), and 
 
Aire
 
 (27) by PCR, and H-2
 
k 
 
Aire
 
 
 
/0 
 
mice of appropriate
HEL:TCR genotype were intercrossed to produce 
 
Aire
 
0/0 
 
H-2
 
k
 
HEL:TCR double transgenic mice. Additional crosses (e.g., HEL
 
Aire
 
 
 
/0
 
 
 
  
 
TCR 
 
Aire
 
0/0
 
) were used to increase the numbers of rare
genotypes for experimental groups. Additional crosses were not
considered for analysis of breeding performance. Experimental
mice were age/sex matched, housed under identical conditions,
and confirmed twice for genotype by PCR. All animal experi-
ments were approved by the Animal Ethics and Experimentation
Committee of the Australian National University.
 
Immunofluorescence Analysis.
 
Rat anti-AIRE mAbs were pro-
duced in the Monoclonal Antibody Facility at Walter and Eliza
Hall Institute of Medical Research by standard polyethylene glycol
fusion. Clone 5H12 (IgG2c) was generated to a 21–amino acid
peptide corresponding to the 20 COOH-terminal amino acids of
Aire with a C residue at the NH
 
2 
 
terminus for KLH conjugation.
Thymi frozen in OCT compound were sectioned (8 
 
 
 
m), stained
with rat anti-Aire mAb and rabbit anti-cytokeratin (DakoCytoma-
tion), followed by Alexa 488 anti–rat IgG and Alexa 568–conju-
gated anti–rabbit IgG, and mounted with fluorescent mounting
medium (DakoCytomation). Images were acquired on a confocal
microscope (MRC 1024; Bio-Rad Laboratories) with a three-line
Kr/Ar laser (excitation lines 488, 568, and 647 nm).
 
HEL Expression on Pancreatic 
 
  
 
Cells and in Serum.
 
Pancreatic
islets were extracted from mice using a protocol modified from
Bowen et al. (35), by infusing the common bile duct with Lib-
erase R1 (Boehringer) and hand-picking islets. From purified is-
lets, a single cell suspension was prepared by incubation with
0.25% trypsin (Boehringer) in HBSS at 37
 
 
 
C for 10 min, and
stained with HyHEL9-tricolor. Serum HEL measurement was
performed by capture on Ig-HEL-Tg spleen cells (36), staining
with HyHEL9-tricolor (37), and flow cytometry as described in
Zhang et al. (38).
 
Thymic Stroma Preparation.
 
Thymic stroma was enriched from
the thymus of 6–12-wk-old transgenic mice as described previ-
ously (39). After enzymatic enrichment, CD45
 
  
 
thymic stromal
cells were purified using CD45 microbeads (Miltenyi Biotec) and
the AutoMACS system (Miltenyi Biotec), as per the manufac-
turer’s recommendations. Purity was 
 
 
 
98% as assessed by staining
with FITC-conjugated anti-CD45.2 (clone 104; BD Biosciences).
 
HEL mRNA Measurement.
 
RNA was purified using the Tri-
zol reagent (Invitrogen) and reverse transcribed into cDNA using
oligo-dT and Superscript III (Invitrogen), as per the manu-
facturer’s recommendations. Quantitative real-time PCR was
performed using the Applied Biosystems Sybr Green master-mix
system, primers for HEL (caacacccaggctacaaacc and gtttccatcgct-
gacgatct), insulin I (aaaggctctttacctggtgtgtgg and actgatccacaatgc-
cacgcttct), or 
 
  
 
actin (cgtgaaaagatgacccagatca and tggtacgaccagag-
gcatacag), and an ABI SDS7700 real-time PCR analyzer (Applied
Biosystems). Cycle conditions were as follows: HEL: 95
 
 
 
C for 15
min followed by 40 cycles at 94
 
 
 
C for 15 s, 65
 
 
 
C for 30 s, and
72
 
 
 
C for 30 s; 
 
  
 
actin/insulin: 95
 
 
 
C 15 min followed by 40 cycles
at 94
 
 
 
C for 15 s, 60
 
 
 
C for 30 s, and 72
 
 
 
C for 30 s. Units of rela-
tive expression were calculated using the exponential of the dif-
ference in the cycle number at which the HEL and 
 
  
 
actin reac-
tions crossed the threshold value, relative to the nontransgenic
sample.
 
Flow Cytometry.
 
6–12-wk-old mice were analyzed as de-
scribed previously (40) using the following antibodies: 1G12 anti-
clonotype (41) culture supernatant followed by rat anti–mouse
IgG1 allophycocyanin; anti–CD8
 
 
 
-PerCP; anti–CD4-FITC or
PE, anti–CD3-PE, and anti–CD69-PE (all from BD Bio-
sciences); and anti–CD5-FITC and anti–CD25-PE (both from
Caltag). Pancreatic islet cells were stained using HyHEL9-TC
(purified and conjugated in our laboratory), with 
 
  
 
islet cells dis-
tinguished by forward and side scatter. 
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Diabetes Incidence Study.
 
Urine glucose was tested using Tes-
tape/Glucostix at biweekly intervals or when the cage was wet.
Mice with two successive positive Testapes were called diabetic,
killed, and diabetes was confirmed by blood glucose measurement
using a standard glucometer. Nondiabetic mice were culled at 24
wk. From each mouse, the pancreas was fixed in 10% formalin,
paraffin embedded, and stained with hematoxylin and eosin.
 
Statistical Analysis.
 
A Student’s 
 
t
 
 test was used for all statistical
analyses referred to in the text, except for the diabetes incidence
study, which was analyzed by a log rank test and fitting to the cox
proportional hazards model. Results were considered significant
if P 
 
  
 
0.05.
 
Results
 
AIRE Expression in the Thymus.
 
The effects of a tar-
geted mutation in 
 
Aire
 
 (27) on thymic Aire protein was
measured by immunofluorescent staining with an Aire
mAb in thymic sections from 
 
Aire
 
 
 
/
 
 
 
, 
 
Aire
 
 
 
/0
 
, and 
 
Aire
 
0/0
 
mice. Aire was observed in relatively high abundance in
the thymic medulla of 
 
Aire
 
 
 
/
 
  
 
(Fig. 1 A) and 
 
Aire
 
 
 
/0 
 
(Fig. 1
B) mice, but not in 
 
Aire
 
0/0 
 
mice (Fig. 1 C). The number of
Aire-expressing cells was not changed by the loss of a single
copy of 
 
Aire
 
, with 85 
 
  
 
15.5 Aire-expressing cells per
0.196 mm
 
2 
 
in the medulla of B10.Br (
 
Aire
 
 
 
/
 
 
 
) mice, and
89 
 
  
 
16.7 Aire-expressing cells per 0.196 mm
 
2 
 
in the medulla
of 
 
Aire
 
 
 
/0 
 
mice (average and standard deviation of 16 areas
from two different thymi for each group). However, loss of
a single copy of 
 
Aire
 
 did appear to reduce the amount of
Aire per cell, as Aire-expressing cells in the 
 
Aire
 
 
 
/
 
  
 
medulla
exhibited a more solid pattern of staining (Fig. 1 D),
whereas Aire-expressing cells in the 
 
Aire
 
 
 
/0 
 
medulla had a
more grainy pattern, which is likely to reflect less protein
per cell (Fig. 1 E). The difference in appearance of Aire-
expressing cells was distinct enough to allow discrimination
between 
 
Aire
 
 
 
/
 
  
 
and 
 
Aire
 
 
 
/0 
 
sections by blind analysis.
 
Effect of Aire Mutation on Insulin Promoter–driven HEL Ex-
pression.
 
Next, we investigated 
 
Aire
 
’s role in expression
of the well-characterized, organ-specific promoter from
the insulin gene in pancreatic islet 
 
  
 
cells and in two sites
of promiscuous expression, the thymus and testes. For this
purpose, 
 
Aire
 
 knockout mice were crossed with a trans-
genic mouse strain carrying one copy of a gene compris-
ing the rat insulin promoter linked to the sequence
for membrane-bound HEL (insHEL; reference 32). The
transgene was expressed at high levels in 
 
  
 
cells from the
islets of Langerhans, as determined by flow cytometry us-
ing the HEL-recognizing antibody, Hy9 (Fig. 2). Muta-
tion of one or both copies of 
 
Aire
 
, in 
 
Aire
 
 
 
/0 
 
or 
 
Aire
 
0/0
 
transgenic mice, had no effect on expression in 
 
  cells
(Fig. 2). Circulating HEL antigen in the serum, which we
assume is released from   cells, was also not different in
insHEL transgenic Aire / , Aire /0, and Aire0/0 mice (Fig.
Figure 1. Aire expression in the thymus. Immunofluorescent staining of thymic sections showing broad spectrum cytokeratin staining (red) and AIRE
protein levels (green). (A) B10.Br (Aire / ) thymus at a magnification of 20. (B) Aire /0 thymus at a magnification of 20. (C) Aire0/0 thymus at a magnifi-
cation of 20. (D) B10.Br (Aire / ) thymus at a magnification of 60. (E) Aire /0 thymus at a magnification of 60.Gene Dosage–limiting Role of Aire in Autoimmunity 1018
2). Thus, Aire is not required for organ-specific expression
of the insulin promoter.
In contrast, Aire was essential and gene dosage depen-
dent for activation of the insulin promoter in thymic epi-
thelial cells. As HEL protein levels were too low for reli-
able detection by immunofluorescence or flow cytometry
in thymic epithelium (unpublished data), HEL mRNA
was quantitated by real-time PCR. HEL mRNA was be-
low the limit of detection in whole thymus preparations;
however, it was present in purified CD45  thymic stroma
from B10.Br Aire /  insHEL transgenic mice (Fig. 3 A).
Thymic HEL mRNA was absent in Aire0/0 insHEL trans-
genic mice and, surprisingly, was reduced to an intermedi-
ate level in Aire /0 heterozygotes (Fig. 3 A). Aire dose
dependence was not unique to the insulin promoter
fragment in the transgene, but applied equally to thymic
epithelial expression of mRNA from the endogenous in-
sulin gene (Fig. 3 B). It should be noted that these Aire /0
and Aire0/0 mice show all the normal thymic epithelial cell
subsets as determined by FACS analysis with stromal mark-
ers, indicating that loss of insulin promoter activity was not
due to any effect on gross thymic epithelium cell differen-
tiation (unpublished data).
Promiscuous gene expression is also observed in the tes-
tes, and the fact that Aire is weakly expressed in the testes
(24) and that male Aire0/0 mice have reduced fertility (27)
raise the possibility that Aire might also be responsible for
ectopic expression in the testes. To test this hypothesis,
mRNA was purified from insHEL transgenic Aire / ,
Aire /0, and Aire0/0 testes, and HEL mRNA levels were
measured by real-time PCR. The insulin promoter HEL
transgene was expressed as mRNA in the testes, but Aire
Figure 2. Absence of any effect of Aire mutation on insHEL expression
in the   islets and serum. HEL protein concentration in the serum of 6–
12-wk-old insHEL transgenic mice of the indicated Aire genotypes, and
surface expression of HEL protein on pancreatic islet cells. HEL surface
staining of insHEL transgenic islet is shown in gray, and background con-
trol staining of nontransgenic B10.Br islets is shown in white (representative
histogram, n   2).
Figure 3. Activation of the insulin promoter is dependent on Aire in
the thymic stroma and independent of Aire in the testes. (A) Thymic
stroma was purified from pools of 10 thymi of nontransgenic or insHEL
transgenic mice of the indicated Aire genotypes. HEL mRNA, normal-
ized to   actin mRNA, was quantified by mRNA extraction, reverse
transcription, and real-time PCR. The mean and standard deviation of
three separate reactions is shown. (B) Independent samples of thymic
stroma was purified from pools of 10 thymi of Aire / , Aire /0, and
Aire0/0 mice (all nontransgenic for HEL). Endogenous insulin mRNA,
normalized to   actin mRNA, was quantified by mRNA extraction, reverse
transcription, and real-time PCR. The mean and standard deviation of
three separate reactions is shown. (C) Testes were removed from insHEL
transgenic mice of the indicated Aire genotypes, and real-time PCR was
used to measure HEL mRNA displayed in arbitrary units normalized to
the level of   actin mRNA. No HEL mRNA was detected in nontrans-
genic mice (n   1); however, HEL mRNA was ectopically expressed in
B10.Br (Aire / ; n   4), Aire /0 (n   5), and Aire0/0 (n   6) insHEL
transgenic mice. The mean and standard error of biological replicates
(each the average of three technical replicates) is shown.Liston et al. 1019
Figure 4. Effect of Aire deficiency on thymic deletion to
HEL antigen controlled by the insulin, thyroglobulin, and
H-2k promoters. Representative flow cytometric profiles
from  3A9 TCR transgenic mice carrying the indicated
HEL transgenes, and of the indicated Aire genotypes.
Numbers indicate the percentage of plotted cells falling
within the gates shown. (A) CD4 versus CD8 staining of
thymocytes, showing gates used for double negative, DP,
and CD4 SP cells. Mean absolute numbers of thymocytes
with standard deviation is indicated on each representative
profile. (B) Staining for CD69 and clonotypic 1G12 anti-
body to the 3A9 TCR, after gating on CD4  CD8  SP
thymocytes. Gates show the most mature subset of 1G12 
CD69  cells. (C) Staining for CD4 and clonotypic 1G12
on splenic lymphocytes.Gene Dosage–limiting Role of Aire in Autoimmunity 1020
was not required for testicular ectopic expression (Fig. 3
C), indicating that a separate mechanism accounts for ec-
topic expression in the testes.
Impact of Aire Dose-dependent Thymic Activation of the Insu-
lin Promoter on Thymic Deletion. Next, we asked whether
or not the intermediate decrease in thymic HEL mRNA in
heterozygous Aire /0 insHEL transgenic mice had any sig-
nificant impact on the efficiency of thymic deletion. A
large cohort of Aire mutant and control mice were bred to
be doubly transgenic for the insHEL transgene and the 3A9
TCR transgene, which causes most developing T cells to
carry a well-characterized TCR recognizing HEL46-61/
I-Ak. HEL-reactive T cells were tracked through thymic
development using a clonotypic antibody to the 3A9 TCR,
1G12, and a variety of developmental markers (Figs. 4–6).
The results of this analysis showed a profound defect in
thymic deletion in Aire-null homozygotes and an inter-
mediate defect in Aire heterozygotes, thus mirroring the
mRNA data. By staining for the most mature subset of
CD4  CD8  1G12hi CD69  thymocytes (Fig. 4 B), the
number of cells in this subset was dramatically reduced in
B10.Br double transgenic thymus to 3% of those in TCR-
only controls with no insHEL transgene (Fig. 5 B). Muta-
tion of one or both Aire copies interfered with deletion of
mature cells, their frequencies rising 370% in Aire /0 (P  
0.005 vs. B10.Br double transgenic mice) and 1,900% in
Aire0/0 mice (P   10 11 vs. B10.Br double transgenic mice)
compared with Aire /  controls.
The defect in thymic HEL expression in double trans-
genic Aire /0 and Aire0/0 mice also prevented the increase in
proportion of CD4  CD8  1G12hi thymocytes expressing
CD25 that normally occurs in HEL-expressing animals
(Fig. 6). In B10.Br TCR transgenic mice, the presence of
the insHEL transgene increased the percentage of CD4 
CD8  1G12  cells that are CD25  from 3.6 to 25.2%. In
Aire /0 mice, the increase in CD25  cells was significantly
lower at 9.6% and in Aire0/0  mice, the percentage of
CD25  cells actually dropped to 2.3%. When the absolute
numbers of CD4  CD8  1G12  CD25  cells are consid-
ered, however, B10.Br TCR transgenic mice had slightly
higher numbers than B10.Br double transgenic mice (not
depicted). Thus, small numbers of CD4  CD25  3A9 T
cells are produced at basal levels in TCR transgenic mice,
but these appear refractory to deletion when antigen is pro-
duced in the thymus through the action of Aire, resulting in
their relative enrichment among mature thymocytes in
Aire /  double transgenic animals.
Consequence of Heterozygous or Homozygous Aire Mutation
on Circulating Islet-reactive T Cells and Diabetes. The defec-
tive negative selection in the thymus of Aire /0 and Aire0/0
insHEL double transgenic mice is accompanied by higher
numbers of HEL-reactive CD4  T cells in the spleen com-
pared with B10.Br (Aire / ) double transgenic mice (Figs.
4 C and 5 C). Compared with double transgenic control
mice, the frequency of 1G12  CD4  cells was increased by
300% in Aire /0 mice (P   0.0005) and 700% in Aire0/0
mice (P   10 6). The small number of HEL-reactive CD4 
T cells that escape thymic deletion in control insHEL dou-
ble transgenic mice initiate subclinical insulitis. Comparable
insulitis was also observed in Aire /0 and Aire0/0 double
transgenic mice (unpublished data). In the presence of both
functioning copies of Aire, this insulitis rarely progresses to
autoimmune diabetes (24% for B10.Br insHEL double
transgenic mice and 23% for Aire /  sibling insHEL double
transgenic mice). However, loss of a single copy of Aire in-
creased the diabetes incidence in insHEL:TCR mice to
55%. Diabetes incidence rose to 67% in mice missing both
copies of Aire (Fig. 7).
Figure 5. Quantitation of the effects of Aire deficiency on thymic dele-
tion. Thymic and splenic subsets were measured by flow cytometry in
TCR transgenic mice with the indicated HEL transgenes as shown in Fig.
4. Columns show mean number of cells. B10.Br (Aire / ) mice are
shown in black, Aire /0 mice are shown in gray, and Aire0/0 mice are
shown in white. Error bars indicate standard deviation. Groups with low
values have the mean absolute cell number indicated above the column.
(A) Mean number of CD4  CD8  DP thymocytes. (B) Mean number of
mature HEL-reactive CD4 thymocytes (CD4  CD8  1G12hi CD69 ).
(C) Frequency of HEL-reactive 1G12  CD4  T cells in the peripheral
repertoire of the spleen.Liston et al. 1021
The fact that some Aire mutant insHEL:TCR mice were
diabetic at weaning (Fig. 7), together with a lower than ex-
pected frequency of mice of this genotype (Table I), raised
the possibility that some Aire /0 and Aire0/0 double trans-
genic mice were developing diabetes and dying before
weaning. Double transgenic mice were generated by cross-
ing an Aire /0 insHEL transgenic mouse to an Aire /0 TCR
transgenic mouse. Of the double transgenic offspring, a 25:
50:25% composition of Aire / :Aire /0:Aire0/0 mice was ex-
pected. However, genotyping after weaning (Table I) indi-
cated that there was an overrepresentation of Aire /  dou-
ble transgenic mice, with numbers of double transgenic
Aire /0 mice being reduced by 20% and numbers of double
transgenic Aire0/0 mice being reduced by 40% relative to
expected. To observe if this distortion of the expected
Mendelian ratio was due to increased mortality between
birth and weaning, a series of litters were monitored closely
for numbers born and subsequent ill health, and any
pups found dead were genotyped by PCR. The expected
composition of nontransgenic:insHEL transgenic:TCR
transgenic:double transgenic pups is 25:25:25:25%. The
preweaning fatality rate was 8% and deaths were acute
without any signs of preceding illness. Despite cannibalism,
tissue from half of these acute deaths could be recovered for
genotyping, biased toward pups of older ages, as pups dying
soon after birth were often eaten before recovery of a tissue
sample. Although the expected frequency of double trans-
genic pups is 25%, 91% of typable deaths occurred in dou-
ble transgenic mice, with 94% of these being either Aire /0
or Aire0/0 (Table I). Thus, Aire mutant double transgenic
pups have an increased neonatal mortality compared with
sibling controls.
The pancreas was able to be obtained from two dead
pups and analyzed histologically, revealing very few islets
and those remaining being severely inflamed with mono-
nuclear cells. Based on the expected frequency of Aire mu-
tant double transgenic animals (25%), the selective reduc-
tion in frequency of this class when genotyped at weaning
(to 19%), and the 8% preweaning mortality concentrated in
the same class of animals, it appears that  40% of Aire
mutant double transgenic animals die between birth and
weaning. The fact that the losses are confined to mice with
high frequencies of islet-reactive T cells makes it likely that
mortality is due to acute insulin deficiency, although the
rapid cannibalism makes it difficult to determine the cause
of death.
Essential Role for Aire in Thymic Tolerance to Thyroid-specific
Antigen. Because the action of Aire in tolerance to thy-
roid-specific or systemic autoantigens is not known, we
next investigated how complete or partial Aire deficiency
affected thymic deletion in transgenic mice expressing HEL
controlled by the thyroglobulin (TgHEL) or H-2Kb
(H-2kHEL) promoters. 3A9 TCR transgenic Aire0/0 mice
were bred to the TgHEL and H-2kHEL strains, and prog-
eny were backcrossed to produce Aire0/0 and Aire /0 double
transgenic mice. The TgHEL transgenic strain produces
membrane-bound HEL protein at high levels in the thy-
roid epithelium, undetectable levels of sHEL present in the
Figure 6. Effect of Aire deficiency on proportions of au-
toreactive CD4  cells expressing CD25 . Mean percentage
of thymic CD4  CD8  1G12hi cells that are CD25  with
standard deviation. B10.Br (Aire / ) mice are shown in
black, Aire /0 mice are shown in gray, and Aire0/0 mice are
shown in white.
Figure 7. Aire /0 and Aire0/0 double transgenic mice show an enhanced
susceptibility to diabetes. Double transgenic mice of B10.Br (n   40),
Aire /  (n   23), Aire /0 (n   22), and Aire0/0 (n   18) genotypes were
tracked for diabetes incidence from weaning to 24 wk of age. There was a
significant difference between the groups with the log rank test (P  
0.0005). By fitting to the Cox proportional hazards model, the incidence
of diabetes in Aire /0 and Aire0/0 double transgenic mice was significantly
greater than that in B10.Br (Aire / ) and Aire /  double transgenic mice
(P   0.01 and P   0.001). There was no significant difference between
diabetes incidences in Aire /0 and Aire0/0 double transgenic mice.Gene Dosage–limiting Role of Aire in Autoimmunity 1022
circulation (32, 33), and protein expression is readily de-
tected by immunofluorescence in scattered thymic epithe-
lial cells, primarily in the medulla (unpublished data). In-
terestingly, detectable levels of endogenous thyroglobulin
mRNA have been detected in cortical epithelial cells, albeit
at lower levels than medullary epithelial cells (42). It is un-
known whether cortical transcripts of endogenous thyro-
globulin are productive and tolerogenic. The H-2kHEL
strain expresses membrane-bound HEL in all tissues, with
high expression on radioresistant cells and thymocytes (34).
In the thymus of Aire /  TgHEL:TCR mice, double
positive (DP) and single positive (SP) cells were deleted to
a greater degree than in corresponding insHEL double
transgenic mice (Figs. 4, A and B, and 5, A and B), consis-
tent with higher levels of HEL protein in thymic medullary
epithelial cells of TgHEL mice. Thymic deletion in TgHEL
double transgenic mice was completely abolished by ho-
mozygous loss of Aire, so that the number of CD4  CD8 
DP cells and CD4  CD8  1G12hi  CD69  mature thy-
mocytes became indistinguishable from TCR transgenic
controls with no HEL transgene (Fig. 5, A and B). Periph-
eral CD4  T cells bearing the HEL-reactive TCR were
also greatly increased in Aire0/0 TgHEL double transgenic
mice (Fig. 5 C), although not attaining the levels of TCR-
only controls presumably because of peripheral tolerance
mechanisms that are Aire independent. In Aire /0 heterozy-
gotes, thymic deletion of DP cells was also significantly less
efficient, with DP cell numbers intermediate between
Aire /  and Aire0/0 TgHEL double transgenic counterparts
(Fig. 5 A). Although the loss of one copy of Aire decreased
the efficiency of deletion to TgHEL, the process neverthe-
less reached completion during the progression from DP to
mature CD4  CD8  1G12hi CD69  cells (Fig. 5 B) because
these were reduced to 0.9% of TCR control numbers in
Aire /0 animals (compared with 0.4% of TCR controls in
Aire /  TgHEL double transgenic mice).
In contrast to the striking failure of thymic deletion to
antigen controlled by islet- or thyroid-specific promoters,
Aire deficiency had no effect on thymic deletion toward
the systemically expressed H-2kHEL (Figs. 4 and 5). It is
unlikely that this reflects saturation of thymic deletion in
these double transgenic mice, as a marked increase in DP
cells in H-2KHEL double transgenic mice occurs when
thymic deletion is impaired by non-MHC genes from the
nonobese diabetic strain yields (unpublished data).
Discussion
The data above define the critical role for Aire in thymic
mRNA expression, T cell deletion, and autoimmunity to
organ-specific gene products. The findings clarify the patho-
genesis of APS1, providing direct evidence at mRNA, cellu-
lar, and whole system levels for the simple interpretation that
APS1 results from failure of a specialized mechanism for thy-
mic expression and thymic deletion to gene products that
would otherwise only be encountered extrathymically. At
each of these levels, the data show that Aire-induced dele-
tion of organ-specific clones is not a highly buffered process
that can only be disrupted by rare homozygous mutations,
but is in fact remarkably sensitive to small reductions in
function in Aire-heterozygous carriers. The fact that Aire-
induced thymic deletion is prone to failure as a result of
Table I. Breeding Results for insHEL Aire /0   TCR Aire /0 Intercross (Gender Not Constant)
No. mice borna 177
No. mice weaneda 163 (8% fatality rate)
No. dead pups unrecovereda 7
Genotype of recovered dead pupsa 4  Aire0/0 double transgenic
3  Aire /0 double transgenic
Total no. dead pups recoveredb 35
Aire    Aire /0 Aire0/0
Genotype of recovered pups Nontransgenic 0 2 0
insHEL 0 0 1
TCR 0 0 0
Double transgenic 2 21 9
Aire    Aire /0 Aire0/0
Total no. weaned mice genotyped as double transgenicb 36 11 18 7
Observed 31% 50% 19%
Expected 25% 50% 25%
aFrom subcohort of 11 breeder pairs where pups were counted at birth.
bFrom a larger cohort where the number of pups born was not recorded.Liston et al. 1023
small quantitative variations makes this mechanism a prime
candidate for the actions of quantitative susceptibility genes
in common organ-specific autoimmune diseases.
The data here provide direct evidence that Aire’s primary
function is to induce ectopic expression of organ-specific
gene products in thymic medullary epithelium, but not in
the peripheral organ or other ectopic sites. The data estab-
lish that the thymic activity of Aire crosses the species bar-
rier between rat and mouse and that sequences within the
600-bp insulin promoter fragment are sufficient for this ac-
tivity. The   cell–specific transcription factor Pdx-1 binds
to elements within this insulin promoter fragment and plays
a key role in promoting expression in pancreatic islet  
cells. Ectopic expression of Pdx-1 in Isl-1–overexpressing
cells is sufficient to activate insulin gene expression in other
epithelial cell types (43). The Aire-induced activity of the
promoter in the thymus suggests the following two testable
hypotheses: (a) Aire substitutes for Pdx-1 in the thymus, or
(b) Aire acts by inducing Pdx-1 in thymic epithelial cells.
The data establish a critical role for Aire in thymic dele-
tion to thyroid-specific gene products. Transgenic mice
carrying HEL antigen controlled by the thyroglobulin pro-
moter display higher levels of antigen in thymic medullary
epithelium, and thymic deletion is concomitantly much
greater than in corresponding insHEL animals. Despite this
greater activity in Aire /  animals, thymic deletion was
more completely abolished by homozygous loss of Aire
(Figs. 4 and 5). This finding explains the high incidence
of thyroiditis and thyroglobulin-specific autoantibodies in
APS1 patients (44) and Aire-deficient mice (29). In con-
trast, thymic deletion to HEL controlled by the H-2K pro-
moter was entirely unaffected by loss of Aire. There are
two possible interpretations of this result: (a) Any role for
Aire in epithelial differentiation or antigen presentation
might be masked in these animals by the high levels of ex-
pression or expression on nonepithelial cells, or (b) the
function of Aire is limited solely to inducing organ-specific
mRNAs in thymic medullary epithelium. Although we
cannot exclude the first possibility, the latter is favored by
the data here and by evidence that thymic deletion to the
H-2K–controlled antigen is not saturated based on its sensi-
tivity to genetic defects caused by non-MHC genes from
the nonobese diabetic mouse (unpublished data).
Based on the strictly recessive inheritance pattern of
APS1, it might have been concluded that Aire-induced
thymic deletion is an efficient, highly buffered mechanism
that is only disrupted in rare individuals homozygous for
severe loss of function mutations. The findings here show
that this tolerance mechanism is in fact prone to failure as a
result of small quantitative genetic effects. Heterozygosity
for the targeted Aire mutation caused a marked decrease in
thymic expression of the insulin promoter construct and
the endogenous insulin promoter, indicating a semi-domi-
nant effect at this level of gene action. The targeted allele
truncates the encoded Aire protein at amino acid 218 at the
end of exon 5 with a neomycin cassette eliminating exon 6
(27), thus mirroring the most frequent human R257X
nonsense mutation. The targeted allele nevertheless appears
to be a null mutation because immunohistochemical stain-
ing of homozygous mutant tissues failed to detect immu-
noreactivity with a polyclonal antibody raised to a segment
encoded by exon 4 (27). Nevertheless, it cannot be ruled
out that the residual fragment might have a subtle domi-
nant negative effect because the NH2-terminal portion is
stable in vitro (unpublished data) and contains a nuclear lo-
calization signal and an HRS/ASS domain responsible for
homodimerization. The immunofluorescence analysis of
heterozygotes shown in Fig. 1 establishes that the reduced
insulin promoter activity is not due to a reduction in num-
bers of Aire-expressing cells, but may reflect a reduction in
the amount of Aire protein per cell.
The Aire gene dosage–dependent loss of insHEL mRNA
in the thymus was mirrored by a semi-dominant failure of
thymic deletion in insHEL:3A9 TCR double transgenic
animals, resulting in a 300% increase in HEL-specific CD4
T cells escaping the thymus in heterozygotes and a 700%
increase in homozygotes (Fig. 5 C). The fact that thymic
deletion efficiency parallels insHEL mRNA expression in
thymic epithelial cells argues that the primary role of Aire is
to induce thymic expression of organ-specific mRNAs,
rather than an indirect role in antigen presentation by these
cells. The demonstration of gene dose–dependent effects
on thymic expression of the endogenous insulin gene, and
on thymic deletion induced by the thyroglobulin pro-
moter, excludes the possibility that the transgene is uniquely
sensitive to gene dose because of insertion site or elements
missing from the promoter fragment, and indicates that
dosage sensitivity is likely to be a general characteristic of
Aire-induced thymic expression.
The peripheral consequence of this semi-dominant de-
fect in thymic deletion was a clear increase in susceptibility
to autoimmune islet destruction in insHEL:3A9 TCR dou-
ble transgenic mice. The occurrence of diabetes in Aire
heterozygous double transgenic mice (55%) appears to be
intermediate between that of the Aire0/0 mice (65%) and of
wild-type controls (25%). However, although the inci-
dence in both the heterozygous and knockout strains are
significantly greater than that of wild-type siblings, demon-
strating the exquisite sensitivity of thymic tolerance to small
changes in Aire expression, the difference between the
Aire /0 and Aire0/0 strains is not significant. One interpreta-
tion of this result is that susceptibility to diabetes in this
model follows a bipolar distribution rather than a linear
progression, and that the “autoimmune threshold” has al-
ready been crossed by the loss of one copy of Aire.
Preweaning mortality is elevated in Aire /0 and Aire0/0 dou-
ble transgenic animals (Table I), and although the basis for
mortality could not be determined, the fact that it is con-
centrated exclusively in the double transgenic pups, where
there are very large numbers of islet-reactive CD4  T cells
made in the thymus, suggests an autoimmune basis for
these neonatal deaths. Although this is the simplest inter-
pretation of the data, we nevertheless cannot exclude more
complicated explanations such as increased frequency of
cyotoxic T cells or failure of regulatory T cells. It is striking
that the Aire mutation acts semi-dominantly in terms ofGene Dosage–limiting Role of Aire in Autoimmunity 1024
thymic expression, thymic deletion, and autoimmunity in
the sensitized background of insHEL:3A9 TCR double
transgenic mice. It is likely that the direction of the im-
mune system against the pancreas results in borderline au-
toimmunity, where even a small failure in thymic deletion
is able to induce the cascade to autoimmunity.
Aire heterozygosity had contrasting effects on thymic de-
letion induced by insulin- or thyroglobulin-regulated HEL,
indicating that quantitative changes in Aire activity may
only allow increasing numbers of T cells to escape deletion
within a defined “risk zone” of TCR avidity and thymic
peptide/MHC density. Thymic expression in Aire /0 in-
sHEL animals falls below levels needed to prevent escape of
3A9 T cells to the periphery. In comparison, more HEL is
expressed in the thymus of TgHEL animals, and although
thymic deletion of DP cells is markedly less efficient in
TgHEL Aire /0 heterozygotes than in Aire /  counterparts
(Fig. 5 A), it nevertheless remains more efficient than in the
DP compartment of Aire /   insHEL animals. At the
TCRhi CD69  CD4 SP stage, thymic deletion in TgHEL
Aire heterozygotes has progressed to levels comparable to
wild-type controls. This contrast suggests that deletion to
organ-specific antigens depends on probabilistic contacts
with rare cells displaying sufficient autoantigen to induce
apoptosis. When antigen/MHC densities fall, the frequency
of apoptosis-inducing contacts falls proportionally as re-
flected in the intermediate reduction in DP cells in TgHEL
Aire /0 thymi. However, it is only when antigen/MHC
densities lie within a limiting risk zone, as exists in insHEL:
3A9 TCR animals, that the frequency of above threshold
contacts falls so low that significant numbers of high avidity
T cells successfully complete their maturation and escape
the thymus. The comparatively long process of T cell posi-
tive selection and maturation in the thymic medulla may
exist primarily to maximize the chance of rare apoptosis-
inducing contacts and thus minimize the effects of quanti-
tative variation in Aire-induced expression of organ-specific
antigens.
Based on the data of Anderson et al. (29) and for the thy-
roglobulin promoter here, a large number of organ-specific
gene products are likely to depend on Aire for thymic ex-
pression. For each of these there will be a range of potential
epitopes, depending on the MHC haplotype, and a diver-
sity of TCR avidities produced in the thymus against each
of these peptide/MHC epitopes. Hence, it seems likely
that appreciable numbers of forbidden clones in any indi-
vidual may fall into the risk zone for the quantitative de-
fects in thymic deletion observed in the insHELx3A9TCR
combination. Consistent with this view, the strongest in-
herited susceptibility locus in human type 1 diabetes other
than the MHC maps to a common variant of the insulin
gene promoter that decreases thymic expression by two- to
threefold (18, 19). Similarly, mice with fewer copies of the
proinsulin gene and lower thymic proinsulin mRNA dis-
play heightened spontaneous T cell reactivity to proinsulin
in vitro (18, 19, 45). Although differences in insulin pro-
moter efficiency could act directly on   cells by forcing
them to compensate, leading to   cell stress and autoimmu-
nization, the data here provide a firm basis for the view that
subtle reductions in thymic insulin mRNA may indeed in-
crease the frequency of insulin-reactive T cells escaping
thymic deletion and predispose to diabetes. Along similar
lines, mice missing one copy of the myelin protein P0 gene
have half the normal P0 mRNA in the thymus and exhibit
heightened in vitro T cell recall responses that are deter-
mined by the thymus P0 genotype in grafting experiments
(46). Finally, there is an intermediate effect of myelin basic
protein gene heterozygosity on thymic deletion at specific
ages in transgenic mice expressing a high avidity myelin ba-
sic protein–reactive TCR (47). The findings here draw
these different observations together by showing that the
specialized process of Aire-induced thymic deletion to or-
gan-specific gene products is exquisitely sensitive to quanti-
tative perturbations.
The sensitivity of the Aire-induced deletion process to
quantitative effects establishes this pathway as a prime target
for quantitative trait genes, providing a firm biological basis
to guide the design of future gene association studies in
more common organ-specific autoimmune diseases. The
original studies analyzing the penetrance of APS1 found no
evidence for polyendocrine disease in heterozygotes, as an
analysis of 58 patients showed a sibling penetrance of 24–
25%, consistent with a fully recessive inheritance (48), al-
though there are reports of patients with mutations in both
copies of AIRE and autoimmunity, but without the full
APS1 clinical disease (49). It is therefore unlikely that mu-
tation in a single copy of AIRE can be sufficient to lead to
the unique clinical manifestations in APS1 syndrome.
However, no direct studies have been done on the inci-
dence of single autoimmune diseases in human heterozy-
gotes for AIRE mutations, although there are anecdotal re-
ports of autoimmunity that do not meet the criteria for
APS1 in AIRE heterozygotes (50). The only systematic
evaluation of carriers of AIRE mutations analyzed eight
parents of APS1 patients and found that five had subclinical
immune disorders (51).
Moderate elevation in the frequency of forbidden clones
escaping the thymus, as observed here in Aire heterozy-
gotes, may alone be insufficient to precipitate the MHC-
independent polyendocrine autoimmune disease typical of
APS1, but may nevertheless be sufficient to precipitate sin-
gle autoimmune diseases in conjunction with other suscep-
tibility factors. Additive interactions between genetic loci
are difficult to detect by genome-wide scans without a spe-
cific hypothesis because of the problems of correction for
multiple testing and complicating effects of population
stratification. Based on the growing understanding of the
pathway for thymic deletion to organ-specific antigens, the
data here provide a firm basis for testing specific interac-
tions between candidate genes, including Aire, polymor-
phisms in organ-specific genes such as insulin (18, 19),
MHC haplotypes that may present specific autoantigens less
efficiently, variants in genes that modulate TCR signaling
or TCR apoptosis induction such as CD28, CTLA4, or
Bim, and other yet to be defined components of the Aire-
induced thymic deletion pathway. By the same token, it isListon et al. 1025
reasonable to predict that a relatively modest increase in
AIRE activity, if this could be induced by some means,
would markedly lower the incidence of type 1 diabetes and
other organ-specific autoimmune diseases even in individ-
uals with wild-type AIRE. For both of these reasons, it will
be important for future work to define the other compo-
nents in the pathway for AIRE-induced thymic deletion.
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